Dr Rick Turner is an experimental research scientist who spent the first 15 years of his career in academic cardiovascular behavioral medicine research, investigating the putative role of behavioral stress in the etiology of hypertension. He worked at three university medical schools, and published 50 papers in peer-reviewed journals in this research field. He then moved into the pharmaceutical industry as a medical writer, running his own company, Turner Medical Communications LLC, and working for GlaxoSmithKline.
In 2005 he moved to the Campbell University School of Pharmacy (Research Triangle Park, NC) where he is Associate Professor of Clinical Research and the School’s Drug Safety Scholar. His main areas of interest are the design and analysis of clinical trials, and the cardiac safety of noncardiac drugs. He has recently published three books in these areas, and given several talks on cardiac safety at national meetings. He is also a member of the Cardiac Safety Research Consortium.
Dr Turner is also very interested in communicating the scientific and clinical aspects of drug development and pharmacotherapy to the general public, and helping health journalists to report on these issues accurately and informatively. He has been invited to participate in a workshop on “The Pitfalls of Reporting Clinical Trials” at the 6th World Conference of Science Journalists in London, June 2009, and looks forward to participating in more such ventures.
Featured
Animal health and human health are inextricably linked
May 15, 2012
Drug Shortages and the Role of the Middle Man
April 13, 2012
Obamacare's Medical Mercenaries
April 13, 2012
Social Networks
Receive latest news & event updates
Provide email below:
Like CMPI on Facebook
Follow CMPI on Twitter
Connect with CMPI on LinkedIn
Watch our Videos on CMPI YouTube Channel
Subscribe to Receive CMPI RSS Feeds
Donate
Please consider a tax-deductible contribution to CMPI. Your support is appreciated.
